South Dakota Investment Council lifted its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 25.2% in the first quarter, Holdings Channel reports. The firm owned 85,466 shares of the conglomerate’s stock after purchasing an additional 17,217 shares during the period. South Dakota Investment Council’s holdings in Danaher were worth $16,204,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Sivia Capital Partners LLC boosted its position in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP raised its position in Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after purchasing an additional 14,217 shares during the period. Main Street Financial Solutions LLC lifted its stake in shares of Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC lifted its stake in shares of Danaher by 64.2% during the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC boosted its position in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after buying an additional 325 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
DHR stock opened at $196.55 on Thursday. The stock’s 50 day moving average is $187.44 and its two-hundred day moving average is $195.95. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market capitalization of $138.17 billion, a PE ratio of 34.91, a P/E/G ratio of 2.48 and a beta of 0.79. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s payout ratio is presently 28.42%.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on DHR shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. JPMorgan Chase & Co. decreased their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Morgan Stanley dropped their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Evercore reissued an “outperform” rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Finally, Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $228.91.
View Our Latest Research Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
